Cargando…

Comparative Efficacy of Feline Leukemia Virus (FeLV) Inactivated Whole-Virus Vaccine and Canarypox Virus-Vectored Vaccine during Virulent FeLV Challenge and Immunosuppression

Four vaccines for feline leukemia virus (FeLV) are available in the United States. This study's purpose was to compare the efficacy of Nobivac feline 2-FeLV (an inactivated, adjuvanted whole-virus vaccine) and PureVax recombinant FeLV (a live, canarypox virus-vectored vaccine) following FeLV ch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patel, M., Carritt, K., Lane, J., Jayappa, H., Stahl, M., Bourgeois, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2015
Materias:	Vaccines
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4478526/ https://www.ncbi.nlm.nih.gov/pubmed/25972402 http://dx.doi.org/10.1128/CVI.00034-15

Ejemplares similares

Comparative efficacy of the Leucofeligen™ FeLV/RCP and Purevax™ RCP FeLV vaccines against infection with circulating feline Calicivirus
por: Almeras, T., et al.
Publicado: (2017)

Diseases associated with spontaneous feline leukemia virus (FeLV) infection in cats
por: Reinacher, M.
Publicado: (1989)

Could Phylogenetic Analysis Be Used for Feline Leukemia Virus (FeLV) Classification?
por: Cano-Ortiz, Lucía, et al.
Publicado: (2022)

The Diagnosis of Feline Leukaemia Virus (FeLV) Infection in Owned and Group-Housed Rescue Cats in Australia
por: Westman, Mark, et al.
Publicado: (2019)

Acute monoblastic leukemia in a FeLV-positive cat
por: Prihirunkit, Kreangsak, et al.
Publicado: (2008)

Complete Genome Sequence of Feline Leukemia Virus Kawakami-Theilen Strain KT-FeLV-UCD-1
por: Chin, Pei-Ju, et al.
Publicado: (2020)

Development of antibodies to feline IFN-γ as tools to elucidate the cellular immune responses to FeLV
por: Graham, Elizabeth M., et al.
Publicado: (2003)

Recombinant FeLV vaccine: long-term protection and effect on course and outcome of FIV infection
por: Hofmann-Lehmann, R., et al.
Publicado: (1995)

Regulation of FeLV-945 by c-Myb binding and CBP recruitment to the LTR
por: Finstad, Samantha L, et al.
Publicado: (2004)

Exposure of cats to low doses of FeLV: seroconversion as the sole parameter of infection
por: Major, Andrea, et al.
Publicado: (2009)

Comparative measurement of FeLV load in hemolymphatic tissues of cats with hematologic cytopenias
por: Abdollahi-Pirbazari, Mehdi, et al.
Publicado: (2019)

Molecular characterization of Brazilian FeLV strains in São Luis, Maranhão Brazil
por: Martins, Nathálya dos Santos, et al.
Publicado: (2023)

Exploring FeLV-Gag-Based VLPs as a New Vaccine Platform—Analysis of Production and Immunogenicity
por: Ortiz, Raquel, et al.
Publicado: (2023)

Antibody induction after combined application of an adjuvanted recombinant FeLV vaccine and a multivalent modified live virus vaccine with a chlamydial component
por: Brunner, Chantal, et al.
Publicado: (2006)

High prevalence of non-productive FeLV infection in necropsied cats and significant association with pathological findings
por: Suntz, M., et al.
Publicado: (2010)

Difficulties in demonstrating long term immunity in FeLV vaccinated cats due to increasing age-related resistance to infection
por: Wilson, Stephen, et al.
Publicado: (2012)

Viral Determinants of FeLV Infection and Pathogenesis: Lessons Learned from Analysis of a Natural Cohort
por: Bolin, Lisa L., et al.
Publicado: (2011)

Segregation of RD-114 and FeLV-related sequences in crosses between domestic cat and leopard cat
por: BENVENISTE, RAOUL E., et al.
Publicado: (1975)

Clinicopathological findings of FeLV- positive cats at a secondary referral center in Florida, USA (2008–2019)
por: Pare, Amelie, et al.
Publicado: (2022)

Novel approach of dermatophytosis eradication in shelters: effect of Pythium oligandrum on Microsporum canis in FIV or FeLV positive cats
por: Načeradská, Martina, et al.
Publicado: (2021)

Follow-Up of Viral Parameters in FeLV- or FIV-Naturally Infected Cats Treated Orally with Low Doses of Human Interferon Alpha
por: Gomez-Lucia, Esperanza, et al.
Publicado: (2019)

First description of a multisystemic and lethal SARS-CoV-2 variant of concern P.1 (Gamma) infection in a FeLV-positive cat
por: Carneiro, Rodrigo Lima, et al.
Publicado: (2022)

Evaluation of concurrent vaccinations with recombinant canarypox equine influenza virus and inactivated equine herpesvirus vaccines
por: Lee, Dong-Ha, et al.
Publicado: (2022)

Murine leukemia viruses (MuLV) and Xenotropic MuLV-related viruses exhibit inter-tropic complex recombination patterns
por: Prosperi, Mattia C F, et al.
Publicado: (2011)

Protection from Hendra virus infection with Canarypox recombinant vaccine
por: Guillaume-Vasselin, Vanessa, et al.
Publicado: (2016)

Anti-SU Antibody Responses in Client-Owned Cats Following Vaccination against Feline Leukaemia Virus with Two Inactivated Whole-Virus Vaccines (Fel-O-Vax(®) Lv-K and Fel-O-Vax(®) 5)
por: Westman, Mark, et al.
Publicado: (2021)

Neutralizing Antibody Responses to Antigenically Drifted Influenza A(H3N2) Viruses among Children and Adolescents following 2014-2015 Inactivated and Live Attenuated Influenza Vaccination
por: Levine, Min Z., et al.
Publicado: (2016)

Novel Respiratory Syncytial Virus-Like Particle Vaccine Composed of the Postfusion and Prefusion Conformations of the F Glycoprotein
por: Cimica, Velasco, et al.
Publicado: (2016)

B-Cell Responses to Intramuscular Administration of a Bivalent Virus-Like Particle Human Norovirus Vaccine
por: Ramani, Sasirekha, et al.
Publicado: (2017)

Development of a Novel Virus-Like Particle Vaccine Platform That Mimics the Immature Form of Alphavirus
por: Urakami, Akane, et al.
Publicado: (2017)

Dose Selection for an Adjuvanted Respiratory Syncytial Virus F Protein Vaccine for Older Adults Based on Humoral and Cellular Immune Responses
por: Falloon, Judith, et al.
Publicado: (2017)

Erratum in Volume LV
Publicado: (1841)

3D Strain helps relating LV function to LV and structure in athletes
por: Stefani, Laura, et al.
Publicado: (2014)

Modulation of erythropoiesis by the helper-independent Friend leukemia virus F-MuLV
Publicado: (1982)

Rapid genotyping of tilapia lake virus (TiLV) using Nanopore sequencing
por: Delamare‐Deboutteville, Jerome, et al.
Publicado: (2021)

Immunization of Nile Tilapia (Oreochromis niloticus) Broodstock with Tilapia Lake Virus (TiLV) Inactivated Vaccines Elicits Protective Antibody and Passive Maternal Antibody Transfer
por: Mai, Thao Thu, et al.
Publicado: (2022)

Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies
por: Kamal, Ram P., et al.
Publicado: (2017)

Molecular and phylogenetic analyses of a new Amphotropic murine leukemia virus (MuLV-1313)
por: Howard, Thomas M, et al.
Publicado: (2006)

Embolised ASD device in LV
por: Raut, Monish S., et al.
Publicado: (2016)

Dr. Lothrop.—Volume LV
Publicado: (1899)

Cannot write session to /tmp/vufind_sessions/sess_d33153avmuu2o7qvp60cooqapk